GEN Exclusives

More »

GEN News Highlights

More »
Dec 1, 2010

Gen-Probe’s Panther MDx System CE Marked and Launched in Europe

Gen-Probe’s Panther MDx System CE Marked and Launched in Europe

Initial tests for the system include Aptima assays for gonorrhea and chlamydia.[Stefan]

  • Gen-Probe has been granted a CE mark for its automated molecular diagnostics system, Panther™. Tests initially available for use with Panther include the sexually transmitted infection assays, Aptima Combo 2®, Aptima CT (chlamydia), and Aptima GC (gonorrhea) assays. A number of other qualitative and quantitative assays are also in development, Gen-Probe notes. Panther will be launched immediately in Europe but has yet to be sanctioned by FDA for commercialization in the U.S., the firm adds.

    Panther has been designed as a “sample-in-result-out” instrument that fully automates all aspects of nucleic acid testing for small- to medium-sized laboratories. Developed to build on the success of Gen-Probe’s existing Tigris® system for large diagnostics laboratories, the Panther platform reportedly allows a single operator to process 275 samples in eight hours, with just one hour of hands-on time. For higher throughput the system is capable of processing 500 samples in 12 hours, Gen-Probe states.

    Panther has been over three years in development, and European launch has been achieved a month ahead of schedule, remarks Carl Hull, Gen-Probe president and CEO. “We believe the Panther system will revolutionize molecular diagnostics by offering customers high levels of productivity and instrument flexibility that were once reserved for high-throughput clinical chemistry and immunoassay systems.”

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »